Research Article

Is Early Flare After Extracorporeal Shock Wave Therapy a Marker of Favorable Clinical Response in Plantar Fasciitis: A Retrospective Cohort Study

Volume: 10 Number: 2 August 31, 2026

Is Early Flare After Extracorporeal Shock Wave Therapy a Marker of Favorable Clinical Response in Plantar Fasciitis: A Retrospective Cohort Study

Abstract

Purpose: This study aimed to investigate whether an early pain flare following extracorporeal shock wave therapy (ESWT) serves as a marker for favorable short-term clinical outcomes in patients with plantar fasciitis (PF) and to examine the association between calcaneal spur characteristics and flare occurrence. 

Materials and Methods: This retrospective observational cohort study included 69 adults (aged 18–65) diagnosed with PF at a tertiary center between April and October 2025. All patients completed a standardized ESWT protocol consisting of three weekly sessions (12 Hz, 3.0 bar, 2000 shocks/session) without local anesthesia. Patients were categorized as flare-positive if they experienced a transient increase in heel pain within 72 hours post-treatment. Pain and function were assessed using the Visual Analog Scale (VAS) and Foot Function Index (FFI) at baseline and end of treatment. Statistical analyses included paired t-tests, Wilcoxon signed-rank tests, independent samples t-tests, and ANCOVA models to adjust for baseline imbalances. 

Results: An early flare occurred in 26 patients (37.7%), typically within hours of treatment. Both groups showed significant improvements in VAS and FFI scores (p<0.05). However, there were no significant differences between groups in absolute change scores for pain or function. After adjusting for baseline scores, flare status was not independently associated with pain reduction (p=0.701) or functional recovery (p=0.435). Calcaneal spur presence and length were not associated with flare occurrence.  

Conclusion: Early pain flare is a common, self-limited reaction following ESWT but does not predict superior short-term clinical response in plantar fasciitis.

Keywords

Supporting Institution

Funding The authors received no financial support for the research, authorship, and/or publication of this article. Conflicts of Interest Statement The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Ethical Statement

Ethical approval was obtained from the Ministry of Health Antalya City Hospital Clinical Research Ethics Committee (27.11.2025, no:17/144). The requirement for informed consent was waived due to the retrospective nature of the study.

Thanks

The authors thank Kader Koç (clinical secretary) for assistance with retrieval and organization of archived medical records. The authors declare that no financial support was received for this study.

References

  1. Alhakami AM, Babkair RA, Sahely A, et al. Effectiveness of therapeutic ultrasound on reducing pain intensity and functional disability in patients with plantar fasciitis: a systematic review of randomized controlled trials. PeerJ. 2024;12:e17147. doi:10.7717/peerj.17147
  2. Richer L, Fortin E, Gagnon G, et al. Impact of plantar fasciitis on postural control and walking in young middle-aged adults. Foot (Edinb). 2022;53:101951. doi: 10.1016/j.foot.2022.101951
  3. Lemont H, Ammirati KM, Usen N. Plantar fasciitis: a degenerative process (fasciosis) without inflammation. J Am Podiatr Med Assoc. 2003;93(3):234-237. doi: 10.7547/87507315-93-3-234
  4. Goff JD, Crawford R. Diagnosis and treatment of plantar fasciitis. Am Fam Physician. 2011;84(6):676-682. https://pubmed.ncbi.nlm.nih.gov/21916393/
  5. Mittermayr R, Hartinger J, Antonic V, et al. Extracorporeal shock wave therapy minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis. Ann Surg. 2011;253(5):1024-1032. doi: 10.1097/SLA.0b013e3182121d6e
  6. Vetrano M, d'Alessandro F, Torrisi MR, et al. Extracorporeal shock wave therapy promotes cell proliferation and collagen synthesis of primary cultured human tenocytes. Knee Surg Sports Traumatol Arthrosc. 2011;19(12):2159-2168. doi: 10.1007/s00167-011-1534-9
  7. Charles R, Fang L, Zhu R, et al. The effectiveness of shockwave therapy on patellar tendinopathy, Achilles tendinopathy, and plantar fasciitis: a systematic review and meta-analysis. Front Immunol. 2023;14:1193835. doi: 10.3389/fimmu.2023.1193835
  8. Melese H, Alamer A, Getie K, et al. Extracorporeal shock wave therapy on pain and foot functions in subjects with chronic plantar fasciitis: systematic review of randomized controlled trials. Disabil Rehabil. 2022;44(18):5007-5014. doi: 10.1080/09638288.2021.1928775

Details

Primary Language

English

Subjects

Pain, Rheumatology and Arthritis, Sports Medicine

Journal Section

Research Article

Publication Date

August 31, 2026

Submission Date

March 13, 2026

Acceptance Date

July 3, 2026

Published in Issue

Year 2026 Volume: 10 Number: 2

APA
Duman Şahin, Z., Yılmaz Muluk, S., Altuntaş, V., Aslan, E., Dirican, Ş., & Uğur, S. (2026). Is Early Flare After Extracorporeal Shock Wave Therapy a Marker of Favorable Clinical Response in Plantar Fasciitis: A Retrospective Cohort Study. Ahi Evran Medical Journal, 10(2), 302-311. https://doi.org/10.46332/aemj.1909378
AMA
1.Duman Şahin Z, Yılmaz Muluk S, Altuntaş V, Aslan E, Dirican Ş, Uğur S. Is Early Flare After Extracorporeal Shock Wave Therapy a Marker of Favorable Clinical Response in Plantar Fasciitis: A Retrospective Cohort Study. Ahi Evran Med J. 2026;10(2):302-311. doi:10.46332/aemj.1909378
Chicago
Duman Şahin, Zehra, Selkin Yılmaz Muluk, Vedat Altuntaş, Evin Aslan, Şevval Dirican, and Sevcan Uğur. 2026. “Is Early Flare After Extracorporeal Shock Wave Therapy a Marker of Favorable Clinical Response in Plantar Fasciitis: A Retrospective Cohort Study”. Ahi Evran Medical Journal 10 (2): 302-11. https://doi.org/10.46332/aemj.1909378.
EndNote
Duman Şahin Z, Yılmaz Muluk S, Altuntaş V, Aslan E, Dirican Ş, Uğur S (August 1, 2026) Is Early Flare After Extracorporeal Shock Wave Therapy a Marker of Favorable Clinical Response in Plantar Fasciitis: A Retrospective Cohort Study. Ahi Evran Medical Journal 10 2 302–311.
IEEE
[1]Z. Duman Şahin, S. Yılmaz Muluk, V. Altuntaş, E. Aslan, Ş. Dirican, and S. Uğur, “Is Early Flare After Extracorporeal Shock Wave Therapy a Marker of Favorable Clinical Response in Plantar Fasciitis: A Retrospective Cohort Study”, Ahi Evran Med J, vol. 10, no. 2, pp. 302–311, Aug. 2026, doi: 10.46332/aemj.1909378.
ISNAD
Duman Şahin, Zehra - Yılmaz Muluk, Selkin - Altuntaş, Vedat - Aslan, Evin - Dirican, Şevval - Uğur, Sevcan. “Is Early Flare After Extracorporeal Shock Wave Therapy a Marker of Favorable Clinical Response in Plantar Fasciitis: A Retrospective Cohort Study”. Ahi Evran Medical Journal 10/2 (August 1, 2026): 302-311. https://doi.org/10.46332/aemj.1909378.
JAMA
1.Duman Şahin Z, Yılmaz Muluk S, Altuntaş V, Aslan E, Dirican Ş, Uğur S. Is Early Flare After Extracorporeal Shock Wave Therapy a Marker of Favorable Clinical Response in Plantar Fasciitis: A Retrospective Cohort Study. Ahi Evran Med J. 2026;10:302–311.
MLA
Duman Şahin, Zehra, et al. “Is Early Flare After Extracorporeal Shock Wave Therapy a Marker of Favorable Clinical Response in Plantar Fasciitis: A Retrospective Cohort Study”. Ahi Evran Medical Journal, vol. 10, no. 2, Aug. 2026, pp. 302-11, doi:10.46332/aemj.1909378.
Vancouver
1.Zehra Duman Şahin, Selkin Yılmaz Muluk, Vedat Altuntaş, Evin Aslan, Şevval Dirican, Sevcan Uğur. Is Early Flare After Extracorporeal Shock Wave Therapy a Marker of Favorable Clinical Response in Plantar Fasciitis: A Retrospective Cohort Study. Ahi Evran Med J. 2026 Aug. 1;10(2):302-11. doi:10.46332/aemj.1909378

Ahi Evran Medical Journal  is indexed in ULAKBIM TR Index, Turkish Medline, DOAJ, Index Copernicus, EBSCO and Turkey Citation Index. Ahi Evran Medical Journal is periodical scientific publication. Can not be cited without reference. Responsibility of the articles belong to the authors.

    Creative Commons Lisansı

This journal is licensed under the Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı.